Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

CREATE

MEDIUS HOLDINGS

ALBIS

ナガホリ

NARASAKI SANGYO

COSMO BIO COMPANY,LIMITED

TOKYO NISSAN COMPUTER SYSTEM

SATORI ELECTRIC

DAIKO DENSHI TSUSHIN

TOKYO BOEKI

Chiyoda Kohan

ヤギ

OSAKA KOHKI

CHARLE

小津産業

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

NIPPON COKE & ENGINEERING

Nissan Motor

Nittetsu Mining

SANKEI CHEMICAL

メルコホールディングス

Financial Indicator Details: Japan Lifeline (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: Japan Lifeline (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	- (-0.78%)	2.54% (-0.67%)	3.45% (1.11%)	3.11% (1.04%)	2.36% (0.14%)
C/F margin (Industry Average)	- (2.64%)	2.76% (3.04%)	5.69% (2.58%)	5.84% (2.72%)	3.71% (3.01%)
ROA (Industry Average)	- (-0.93%)	2.53% (-0.26%)	3.25% (2.02%)	2.74% (1.64%)	1.91% (1.86%)
ROE (Industry Average)	- (-8.29%)	3.96% (-0.51%)	5.25% (4.78%)	4.77% (7.42%)	3.36% (10.52%)
Growth	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	2.32% (-0.20%)	3.53% (8,903.19%)	2.53% (3.48%)	2.28% (7.03%)
Sales growth (Industry Average)	- (-)	- (-)	1.22% (-8,084.01%)	3.48% (4.75%)	-5.16% (2.25%)
Net profit growth (Industry Average)	- (-)	- (93.72%)	37.17% (-53,131.49%)	-6.73% (115.02%)	-27.91% (-35.44%)
Operating C/F growth (Industry Average)	- (-)	- (285.33%)	108.11% (-12,776.43%)	6.30% (137.06%)	-39.71% (277.80%)
Stability	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	63.80% (42.71%)	63.80% (41.20%)	61.97% (42.85%)	57.44% (42.63%)	56.84% (44.26%)
Liquidity ratio (Industry Average)	323.85% (179.54%)	324.16% (175.85%)	283.38% (180.41%)	217.25% (181.91%)	219.46% (188.36%)
C/F ratio current liabilities (Industry Average)	- (1,980.37%)	883.19% (1,315.76%)	476.93% (1,341.70%)	597.52% (2,369.89%)	972.75% (-1,473.15%)
Quick ratio (Industry Average)	184.50% (127.56%)	180.20% (128.85%)	151.93% (130.25%)	116.68% (131.24%)	108.96% (134.71%)
Turnover	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	- (66.26day)	107.37day (72.58day)	107.03day (71.22day)	107.93day (74.24day)	106.04day (73.78day)
Inventory turnover (Industry Average)	- (23.43day)	105.94day (24.20day)	109.40day (24.10day)	105.89day (23.74day)	122.22day (23.74day)
Payable turnover (Industry Average)	- (47.41day)	20.31day (56.89day)	25.17day (53.81day)	22.94day (54.73day)	23.74day (54.15day)
Working capita turnover (Industry Average)	- (42.28day)	193.01day (39.89day)	191.25day (41.51day)	190.88day (43.25day)	204.51day (43.37day)
Stock etc.	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	- (24.40%)	- (2.34%)	- (12.54%)	- (22.07%)
Dividend Yield (Industry Average)	- (3.71%)	- (2.43%)	- (2.57%)	- (2.50%)	- (2.29%)
PER (Industry Average)	- (17.73%)	- (-42,505.05%)	- (26.18%)	- (13.38%)	- (14.02%)
PBR (Industry Average)	- (0.68%)	- (2,493.11%)	- (0.75%)	- (0.75%)	- (0.94%)
PCFR (Industry Average)	- (8.77%)	- (-56,697.69%)	- (14.53%)	- (3.94%)	- (6.84%)
PSR (Industry Average)	- (0.24%)	- (627.96%)	- (0.27%)	- (0.27%)	- (0.36%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	0.95% (-5.78%)	2.88% (-4.82%)	3.93% (-7.87%)	2.85% (5.39%)	2.48% (-16.99%)
C/F margin (Industry Average)	17.29% (0.94%)	- (0.68%)	- (0.24%)	- (0.42%)	- (0.40%)
ROA (Industry Average)	0.87% (-1.62%)	2.70% (-0.89%)	3.56% (1.12%)	2.44% (1.61%)	1.94% (1.68%)
ROE (Industry Average)	1.34% (-4.55%)	4.13% (1.49%)	5.51% (2.42%)	4.08% (11.69%)	3.28% (3.68%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	2.50% (1.54%)	3.82% (2,759.04%)	1.80% (5.68%)	2.19% (4.49%)
Sales growth (Industry Average)	- (-)	4.91% (-8.70%)	1.46% (-24,467.79%)	4.06% (3.17%)	-5.82% (-0.50%)
Net profit growth (Industry Average)	- (-)	215.59% (871.31%)	38.48% (37,301.93%)	-24.57% (18.43%)	-17.91% (-18.89%)
Operating C/F growth (Industry Average)	- (-)	- (34.36%)	- (34.97%)	- (107.23%)	- (419.92%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	65.39% (48.34%)	65.34% (47.50%)	64.55% (48.47%)	59.93% (49.17%)	59.09% (49.18%)
Liquidity ratio (Industry Average)	331.30% (210.76%)	334.28% (289.28%)	296.60% (209.41%)	223.01% (195.18%)	- (184.34%)
C/F ratio current liabilities (Industry Average)	146.38% (-35.94%)	- (476.46%)	- (97.20%)	- (262.51%)	- (175.49%)
Quick ratio (Industry Average)	188.70% (149.43%)	182.92% (157.91%)	154.78% (148.93%)	113.75% (136.41%)	- (108.70%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	116.90day (64.33day)	108.08day (91.51day)	107.16day (103.30day)	107.64day (103.68day)	- (84.78day)
Inventory turnover (Industry Average)	99.75day (15.37day)	110.60day (17.83day)	115.44day (17.21day)	112.04day (17.47day)	- (9.13day)
Payable turnover (Industry Average)	24.75day (46.24day)	18.49day (76.20day)	22.99day (83.33day)	20.49day (85.88day)	- (74.92day)
Working capita turnover (Industry Average)	191.90day (33.47day)	200.18day (33.14day)	199.61day (37.18day)	199.19day (35.27day)	- (18.99day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	- (23.66%)	- (3.37%)	- (11.64%)	- (20.93%)
Dividend Yield (Industry Average)	- (0.22%)	- (0.17%)	- (0.15%)	- (0.19%)	- (0.19%)
PER (Industry Average)	- (465.89%)	- (13,043.05%)	- (13.79%)	- (4.97%)	- (27.49%)
PBR (Industry Average)	- (0.78%)	- (3,131.13%)	- (0.97%)	- (0.96%)	- (1.20%)
PCFR (Industry Average)	- (-0.12%)	- (0.84%)	- (3.88%)	- (-1.50%)	- (2.05%)
PSR (Industry Average)	- (0.85%)	- (792.34%)	- (1.83%)	- (2.08%)	- (2.31%)

Financial Indicator Details: Japan Lifeline

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	-	2.54%	3.45%	3.11%	2.36%
C/F margin	-	2.76%	5.69%	5.84%	3.71%
ROA	-	2.53%	3.25%	2.74%	1.91%
ROE	-	3.96%	5.25%	4.77%	3.36%
Recurring margin	-	6.44%	4.83%	5.17%	4.44%
EBIT margin	-	5.55%	7.33%	6.94%	5.06%
EBITDA margin	-	6.81%	8.68%	8.95%	7.64%
NOPAT margin	-	3.33%	4.40%	4.16%	3.04%
Sales SG rates	-	49.90%	50.78%	48.39%	48.67%
Sales SG&A rates	-	44.12%	44.86%	46.64%	47.79%
Sales R&D expenses rates	-	1.72%	1.66%	2.22%	2.52%
Sales depreciation rates	-	1.26%	1.34%	2.00%	2.57%
Capital expenditures net sales ratio	-	-2.03%	-9.21%	-6.77%	-4.59%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	2.79%	-17.59%	-2.80%	-12.36%
Equity growth	-	2.32%	3.53%	2.53%	2.28%
Total assets growth	-	2.32%	6.59%	10.62%	3.35%
Sales growth	-	-	1.22%	3.48%	-5.16%
Net profit growth	-	-	37.17%	-6.73%	-27.91%
Operating C/F growth	-	-	108.11%	6.30%	-39.71%
Recurring profit growth	-	-	-24.01%	10.72%	-18.61%
EBIT growth	-	-	33.69%	-1.95%	-30.84%
EBITDA growth	-	-	28.92%	6.72%	-19.03%
NOPAT growth	-	-	33.69%	-1.95%	-30.84%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	63.80%	63.80%	61.97%	57.44%	56.84%
Liquidity ratio	323.85%	324.16%	283.38%	217.25%	219.46%
C/F ratio current liabilities	-	883.19%	476.93%	597.52%	972.75%
Quick ratio	184.50%	180.20%	151.93%	116.68%	108.96%
Fixed ratio	6.93%	8.11%	20.02%	28.02%	32.40%
D/E ratio	12.97%	13.88%	19.45%	31.65%	36.05%
Loan to Value Ratio	8.28%	8.85%	12.05%	18.18%	20.49%
Business investment C/F ratio	-	-73.63%	-161.86%	-115.83%	-123.48%
Liabilities with interest growth	-	9.44%	45.10%	66.83%	16.52%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	-	53.52day	43.57day	40.92day	37.82day
Receivables turnover	-	107.37day	107.03day	107.93day	106.04day
Inventory turnover	-	105.94day	109.40day	105.89day	122.22day
Fixed assets turnover	-	19.03day	48.03day	66.60day	83.07day
Total asset turnover	-	367.51day	387.02day	413.74day	450.92day
Payable turnover	-	20.31day	25.17day	22.94day	23.74day
Capital turnover	-	34.95day	34.52day	33.36day	35.18day
Equity turnover	-	234.49day	239.85day	237.66day	256.35day
Working capita turnover	-	193.01day	191.25day	190.88day	204.51day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 3 B	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B
Accounts receivable-trade	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B
Other Current Assets	¥ 14 B	¥ 14 B	¥ 14 B	¥ 14 B	¥ 15 B
Current Assets	¥ 17 B	¥ 17 B	¥ 17 B	¥ 17 B	¥ 17 B
Tangible Assets	¥ 962 M	¥ 1 B	¥ 2 B	¥ 4 B	¥ 4 B
Intangible Assets	¥ 73 M	¥ 64 M	¥ 49 M	¥ 39 M	¥ 30 M
Investment etc.	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B
Total Assets	¥ 21 B	¥ 22 B	¥ 23 B	¥ 26 B	¥ 27 B
Current Liabilities	¥ 5 B	¥ 5 B	¥ 6 B	¥ 8 B	¥ 7 B
Fixed Liabilities	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B
Liabilities with interest	¥ 1 B	¥ 1 B	¥ 2 B	¥ 4 B	¥ 5 B
Net Assets	¥ 13 B	¥ 14 B	¥ 14 B	¥ 15 B	¥ 15 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Capital surplus etc.	¥ 11 B	¥ 12 B	¥ 12 B	¥ 12 B	¥ 13 B
Liabilities and net assets	¥ 21 B	¥ 22 B	¥ 23 B	¥ 26 B	¥ 27 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	-	¥ 22 B	¥ 22 B	¥ 23 B	¥ 21 B
Cost of Sales	-	¥ 11 B	¥ 11 B	¥ 11 B	¥ 10 B
Gross profit	-	¥ 11 B	¥ 11 B	¥ 11 B	¥ 11 B
Other income	-	¥ 151 M	¥ 752 M	¥ 551 M	¥ 488 M
SG&A	-	¥ 9 B	¥ 10 B	¥ 10 B	¥ 10 B
Other expenses	-	¥ 908 M	¥ 953 M	¥ 979 M	¥ 743 M
Net income	-	¥ 562 M	¥ 772 M	¥ 720 M	¥ 519 M
Operating income	-	¥ 1 B	¥ 973 M	¥ 1 B	¥ 774 M
Ordinary Income	-	¥ 1 B	¥ 1 B	¥ 1 B	¥ 975 M
EBITDA	-	¥ 1 B	¥ 1 B	¥ 2 B	¥ 1 B
Income before income taxes	-	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Depreciation	-	¥ 279 M	¥ 301 M	¥ 464 M	¥ 565 M
R&D expenses	-	¥ 381 M	¥ 371 M	¥ 515 M	¥ 554 M
Income taxes	-	¥ 650 M	¥ 850 M	¥ 872 M	¥ 571 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	¥ 611 M	¥ 1 B	¥ 1 B	¥ 816 M
Investment CF	-	¥ -736 M	¥ -2 B	¥ -2 B	¥ -1 B
Financial CF	-	¥ -113 M	¥ 600 M	¥ 1 B	¥ 452 M
Foreign Exchange Effects	-	-	¥ 124 K	¥ 23 K	¥ 620 K
Net Change in Cash	-	¥ -238 M	¥ -569 M	¥ -74 M	¥ -320 M
Free CF	-	¥ -124 M	¥ -1 B	¥ -1 B	¥ -774 M
Capital expenditures	-	¥ -450 M	¥ -2 B	¥ -1 B	¥ -1 B
Cash dividends paid	-	¥ -269 M	¥ -269 M	¥ -324 M	¥ -271 M
Repayment loans	-	-	¥ -61 M	¥ -189 M	¥ -312 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	-	¥ -270 M	¥ -270 M	¥ -324 M	¥ -270 M
Net income	-	¥ 562 M	¥ 772 M	¥ 720 M	¥ 519 M
Purchase of treasury stock	-	-	¥ -98 K	¥ -19 K	¥ -35 K
Other Change in Stockholders Equity	-	-	-	¥ -2 K	-
Other Change in Net Assets	-	¥ 30 M	¥ 130 K	¥ -23 M	¥ 95 M
Net Change in Net Assets	-	¥ 322 M	¥ 502 M	¥ 372 M	¥ 345 M

Financial Indicator Details: Japan Lifeline

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	0.95%	2.88%	3.93%	2.85%	2.48%
C/F margin	17.29%	-	-	-	-
ROA	0.87%	2.70%	3.56%	2.44%	1.94%
ROE	1.34%	4.13%	5.51%	4.08%	3.28%
Recurring margin	4.14%	7.08%	5.05%	5.11%	4.53%
EBIT margin	3.12%	6.11%	7.79%	6.99%	-
EBITDA margin	4.43%	6.68%	8.29%	7.58%	-
NOPAT margin	1.87%	3.66%	4.67%	4.19%	-
Sales SG rates	49.58%	48.22%	49.88%	48.00%	97.51%
Sales SG&A rates	47.53%	45.28%	45.62%	47.14%	-
Sales R&D expenses rates	1.42%	1.47%	1.26%	1.78%	-
Sales depreciation rates	1.30%	0.56%	0.50%	0.58%	-
Capital expenditures net sales ratio	-2.13%	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-1.91%	-18.16%	-20.37%	-100.00%
Equity growth	-	2.50%	3.82%	1.80%	2.19%
Total assets growth	-	2.57%	5.10%	9.65%	3.65%
Sales growth	-	4.91%	1.46%	4.06%	-5.82%
Net profit growth	-	215.59%	38.48%	-24.57%	-17.91%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	79.09%	-27.64%	5.36%	-16.54%
EBIT growth	-	105.00%	29.30%	-6.53%	-100.00%
EBITDA growth	-	58.10%	25.98%	-4.80%	-100.00%
NOPAT growth	-	105.00%	29.30%	-6.53%	-100.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	65.39%	65.34%	64.55%	59.93%	59.09%
Liquidity ratio	331.30%	334.28%	296.60%	223.01%	-
C/F ratio current liabilities	146.38%	-	-	-	-
Quick ratio	188.70%	182.92%	154.78%	113.75%	-
Fixed ratio	5.32%	5.51%	14.04%	23.08%	-
D/E ratio	12.98%	12.66%	15.58%	27.26%	-
Loan to Value Ratio	8.49%	8.27%	10.06%	16.33%	-
Business investment C/F ratio	-12.36%	-	-	-	-
Liabilities with interest growth	-	-	27.77%	78.04%	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	57.42day	53.68day	43.30day	33.13day	-
Receivables turnover	116.90day	108.08day	107.16day	107.64day	-
Inventory turnover	99.75day	110.60day	115.44day	112.04day	-
Fixed assets turnover	13.88day	14.03day	36.60day	58.83day	-
Total asset turnover	398.47day	389.61day	403.58day	425.26day	468.03day
Payable turnover	24.75day	18.49day	22.99day	20.49day	-
Capital turnover	39.75day	37.89day	37.35day	35.89day	-
Equity turnover	260.56day	254.60day	260.53day	254.89day	276.59day
Working capita turnover	191.90day	200.18day	199.61day	199.19day	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 3 B	¥ 2 B	¥ 2 B	¥ 1 B	-
Accounts receivable-trade	¥ 6 B	¥ 6 B	¥ 6 B	-	-
Other Current Assets	¥ 13 B	¥ 13 B	¥ 13 B	¥ 14 B	-
Current Assets	¥ 16 B	¥ 16 B	¥ 16 B	-	-
Tangible Assets	¥ 738 M	¥ 783 M	¥ 2 B	¥ 3 B	-
Intangible Assets	¥ 44 M	¥ 37 M	¥ 30 M	¥ 24 M	-
Investment etc.	¥ 4 B	¥ 4 B	¥ 4 B	¥ 5 B	¥ 25 B
Total Assets	¥ 21 B	¥ 21 B	¥ 22 B	¥ 25 B	¥ 25 B
Current Liabilities	¥ 4 B	¥ 4 B	¥ 5 B	¥ 7 B	¥ 10 B
Fixed Liabilities	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	-
Liabilities with interest	¥ 1 B	¥ 1 B	¥ 2 B	¥ 4 B	-
Net Assets	¥ 13 B	¥ 14 B	¥ 14 B	¥ 15 B	¥ 15 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	-
Capital surplus etc.	¥ 11 B	¥ 12 B	¥ 12 B	¥ 12 B	¥ 15 B
Liabilities and net assets	¥ 21 B	¥ 21 B	¥ 22 B	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 19 B	¥ 20 B	¥ 20 B	¥ 21 B	¥ 20 B
Cost of Sales	¥ 9 B	¥ 9 B	¥ 10 B	¥ 10 B	¥ 19 B
Gross profit	¥ 9 B	¥ 10 B	¥ 10 B	¥ 11 B	¥ 504 M
Other income	¥ 354 M	¥ 147 M	¥ 741 M	¥ 553 M	-
SG&A	¥ 9 B	¥ 9 B	¥ 9 B	¥ 10 B	-
Other expenses	¥ 727 M	¥ 880 M	¥ 856 M	¥ 981 M	-
Net income	¥ 186 M	¥ 587 M	¥ 814 M	¥ 614 M	¥ 504 M
Operating income	¥ 559 M	¥ 1 B	¥ 929 M	¥ 1 B	¥ 709 M
Ordinary Income	¥ 805 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 918 M
EBITDA	¥ 860 M	¥ 1 B	¥ 1 B	¥ 1 B	-
Income before income taxes	¥ 581 M	¥ 1 B	¥ 1 B	-	-
Depreciation	¥ 253 M	¥ 115 M	¥ 103 M	¥ 126 M	-
R&D expenses	¥ 276 M	¥ 300 M	¥ 261 M	-	-
Income taxes	¥ 395 M	¥ 646 M	¥ 784 M	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 3 B	-	-	-	-
Investment CF	¥ -1 B	-	-	-	-
Financial CF	¥ -930 M	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	¥ 922 M	-	-	-	-
Free CF	¥ 1 B	-	-	-	-
Capital expenditures	¥ -415 M	-	-	-	-
Cash dividends paid	¥ -270 M	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -270 M	¥ -270 M	¥ -270 M	-	-
Net income	¥ 186 M	¥ 587 M	¥ 814 M	-	-
Purchase of treasury stock	¥ -10 M	-	¥ -98 K	-	-
Other Change in Stockholders Equity	¥ -1 K	-	¥ -1 K	¥ -3 K	-
Other Change in Net Assets	¥ -13 M	¥ 30 M	¥ 130 K	-	-
Net Change in Net Assets	¥ -108 M	¥ 347 M	¥ 544 M	-	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Japan Lifeline (Annual )

Statement Type

Annual : Japan Lifeline

First quarter : Japan Lifeline

Second quarter : Japan Lifeline

Third quarter : Japan Lifeline

Analysis Menu

Outline : Japan Lifeline

Statement : Japan Lifeline

Rating : Japan Lifeline

Indicator : Japan Lifeline

Download : Japan Lifeline

Industry Comparison Ranking

Wholesale Trade - EDIUNET Industry Rankings

Wholesale Trade - EDIUNET Credit Rating

Wholesale Trade - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo品川区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/20	リーバイ・ストラウス　..	C	2013-11-30
1/20	TIEMCO	BB	2013-11-30
1/15	イワキ	BBB	2013-11-30
1/15	マルカキカイ	BBB	2013-11-30
1/15	ALTECH	BB	2013-11-30
1/15	Shinwa	BBB	2013-11-30 (Q1)
1/15	ONWARD HOLDINGS	A	2013-11-30 (Q3)
1/15	ガリバーインターナショ..	BBB	2013-11-30 (Q3)
1/15	Morito	A	2013-11-30
1/15	BIKE O	BB→BBB	2013-11-30

EDIUNET Investment News (Wholesale Trade)

1/20 Wholesale Trade (リーバイ・..

1/15 Wholesale Trade (イワキ:BBB ..

1/10 Wholesale Trade (エコーＴＤ:..

1/9 Wholesale Trade (KITAKEI:BBB)

1/8 Wholesale Trade (F&A AQUA HO..

1/7 Wholesale Trade (Wakita:A)

1/6 Wholesale Trade (ADVAN:AA)

12/27 Wholesale Trade (ADVANCE:CC ..

12/26 Wholesale Trade (NAGAILEBEN:..

. Wholesale Trade (OOMITSU CO...

Company Information

Ticker	Market	Industry	Month	report	Rating
Japan Lifeline	7575	OSE JASDAQ	Wholesale Trade	3	Annual	BBB

Related Company

YAMASHITA MEDICAL INSTRUMENTS (Sales ¥ 47 B)

アマガサ (Sales ¥ 6 B)

COSMO BIO COMPANY,LIMITED (Sales ¥ 7 B)

KYODO PAPER HOLDINGS (Sales ¥ 17 B)

CREATE (Sales ¥ 25 B)

小津産業 (Sales ¥ 35 B)

TSUBAKIMOTO KOGYO (Sales ¥ 81 B)

ナガホリ (Sales ¥ 14 B)

DAIKO DENSHI TSUSHIN (Sales ¥ 33 B)

ヤギ (Sales ¥ 113 B)

SATORI ELECTRIC (Sales ¥ 129 B)

ムラキ (Sales ¥ 8 B)

KOBAYASHI METALS (Sales ¥ 19 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .